| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $152.2M | +2.2% | +9.6% |
| Cost of Revenue | $58.5M | -3.6% | +8.8% |
| Gross Profit | $93.7M | +6.3% | +10.2% |
| R&D Expense | $29.5M | -14.8% | -10.6% |
| SG&A Expense | $19.3M | -24.2% | -16.4% |
| Operating Income | $11.7M | +226.0% | +1521.8% |
| Income Tax | -$695K | -157.5% | -126.8% |
| Net Income | $6.5M | +142.9% | +224.5% |
| EPS (Basic) | $0.06 | +146.2% | +220.0% |
| EPS (Diluted) | $0.06 | +146.2% | +220.0% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $87.6M | -28.8% | -66.0% |
| Accounts Receivable | $86.9M | -11.7% | +33.7% |
| Current Assets | $209.2M | -18.0% | -40.0% |
| Total Assets | $1.56B | -3.4% | +2.9% |
| Current Liabilities | $208.1M | -16.3% | +16.3% |
| Total Liabilities | $507.3M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $77.1M | — | — |
| Capital Expenditures | $7.0M | — | — |
| Investing Cash Flow | -$53.6M | — | — |
| Financing Cash Flow | -$59.8M | — | — |
| Free Cash Flow | $70.1M | — | — |
| +19.9% |
| Stockholders' Equity | $1.04B | -1.5% | -4.3% |